{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:37:36Z","timestamp":1790937456264,"version":"4.1.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,3]]},"DOI":"10.1093\/rheumatology\/41.3.329","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:55:00Z","timestamp":1027724100000},"page":"329-337","source":"Crossref","is-referenced-by-count":180,"title":["The role of TNF\u2010\u03b1 in the pathogenesis of inflammation and joint destruction in rheumatoid arthritis (RA): a study using a human RA\/SCID mouse chimera"],"prefix":"10.1093","volume":"41","author":[{"given":"H.","family":"Matsuno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Yudoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Uzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Sawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Yonezawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Saeki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. S.","family":"Panayi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Pitzalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2002,3]]},"reference":[{"key":"key\n\t\t\t\t20170703123012_R1","doi-asserted-by":"crossref","unstructured":"Fox DA. Cytokine blockade as a new strategy to treat rheumatoid arthritis: Inhibition of tumor necrosis factor. Arch Intern Med2000;160:437\u201344.","DOI":"10.1001\/archinte.160.4.437"},{"key":"key\n\t\t\t\t20170703123012_R2","doi-asserted-by":"crossref","unstructured":"Elliott MJ, Maini RN, Feldomann M et al. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor. Arthritis Rheum1993;36:1681\u201390.","DOI":"10.1002\/art.1780361206"},{"key":"key\n\t\t\t\t20170703123012_R3","doi-asserted-by":"crossref","unstructured":"Cope AP, Londei M, Chu R et al. Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor\/CD3 complex: Reversal in vivo by anti\u2010TNF antibodies in patients with rheumatoid arthritis. J Clin Invest1994;94:749\u201360.","DOI":"10.1172\/JCI117394"},{"key":"key\n\t\t\t\t20170703123012_R4","doi-asserted-by":"crossref","unstructured":"Brennan FM, Chantry D, Jackson A, Maini RN, Feldomann M. Inhibitory effect of TNF\u2010\u03b1 antibodies on synovial cell interleukin\u20101 production in rheumatoid arthritis. Lancet1989;334:244\u20137.","DOI":"10.1016\/S0140-6736(89)90430-3"},{"key":"key\n\t\t\t\t20170703123012_R5","doi-asserted-by":"crossref","unstructured":"Kalden\u2010Nemeth D, Gremeeier J, Antoni C, Manger B, Wolf F, Kalden JR. NMR monitoring of rheumatoid arthritis patients receiving anti\u2010TNF\u2010alpha monoclonal antibody therapy. Rheumatol Int1997;16:249\u201355.","DOI":"10.1007\/BF01375657"},{"key":"key\n\t\t\t\t20170703123012_R6","doi-asserted-by":"crossref","unstructured":"Tak PP, Taylor PC, Breedveld FC et al. Decrease in cellularity and expression of adhesion molecules by anti\u2010tumor necrosis factor a monoclonal antibody treatment in patients with rheumatoid arthritis. Arthritis Rheum1996;39:1077\u201381.","DOI":"10.1002\/art.1780390702"},{"key":"key\n\t\t\t\t20170703123012_R7","unstructured":"Kavanaugh A, Cohen S, Cush J. Inhibitors of tumor necrosis factor in rheumatoid arthritis: Will that dog hunt? J Rheumatol1998;25:2049\u201353."},{"key":"key\n\t\t\t\t20170703123012_R8","doi-asserted-by":"crossref","unstructured":"Matsuno H, Sawai T, Nezuka T, Uzuki M, Tsuji H, Nishimoto N, Yoshizaki K. Treatment of rheumatoid synovitis with anti\u2010reshaping human interleukin\u20106 receptor monoclonal antibody: Use of rheumatoid arthritis tissue implants in the SCID mouse model. Arthritis Rheum1998;41:2014\u201321.","DOI":"10.1002\/1529-0131(199811)41:11<2014::AID-ART17>3.0.CO;2-T"},{"key":"key\n\t\t\t\t20170703123012_R9","doi-asserted-by":"crossref","unstructured":"Sakai K, Matsuno H, Morita I et al. Potential withdrawal of rheumatoid synovium by the induction of apoptosis using a novel in vivo model of rheumatoid arthritis. Arthritis Rheum1998;41:1251\u20137.","DOI":"10.1002\/1529-0131(199807)41:7<1251::AID-ART16>3.0.CO;2-B"},{"key":"key\n\t\t\t\t20170703123012_R10","doi-asserted-by":"crossref","unstructured":"Matsuno H, Yudoh K, Morita I et al. Apoptosis is a novel therapeutic strategy for RA: Investigations using an experimental arthritis animal model. In: Takahashi HE, ed. Mechanical loading of bone and joints. Tokyo: Springer, 1999:215\u201326.","DOI":"10.1007\/978-4-431-65892-4_21"},{"key":"key\n\t\t\t\t20170703123012_R11","doi-asserted-by":"crossref","unstructured":"Yudoh K, Matsuno H, Nezuka T, Kimura T. Different mechanisms of synovial hyperplasia in rheumatoid arthritis and pigmented villonodular synovitis: The role of telomerase activity in synovial proliferation. Arthritis Rheum1999;42:669\u201377.","DOI":"10.1002\/1529-0131(199904)42:4<669::AID-ANR9>3.0.CO;2-V"},{"key":"key\n\t\t\t\t20170703123012_R12","doi-asserted-by":"crossref","unstructured":"Matsuno H, Sugiyama E, Muraguchi A et al. Pharmacological effects of SA96 (bucillamine) and its metabolites as immunomodulating drugs. The disulfide structure of SA\u201096 metabolites plays a critical role in the pharmacological action of the drug. Int J Immunopharmacol1998;20:295\u2013304.","DOI":"10.1016\/S0192-0561(98)00012-5"},{"key":"key\n\t\t\t\t20170703123012_R13","doi-asserted-by":"crossref","unstructured":"Koizumi F, Matsuno H, Wakaki K, Ishii Y, Kurashige Y, Nakamura H. Synovitis in rheumatoid arthritis: Scoring characteristic histopathological features. Int Pathol1999;49:298\u2013304.","DOI":"10.1046\/j.1440-1827.1999.00863.x"},{"key":"key\n\t\t\t\t20170703123012_R14","doi-asserted-by":"crossref","unstructured":"Yudoh K, Matsuno H, Nezuka T, Kimura T. Different mechanisms of synovial hyperplasia in rheumatoid arthritis and pigmented villonodular synovitis: The role of telomerase activity in synovial proliferation. Arthritis Rheum1999;42:669\u201377.","DOI":"10.1002\/1529-0131(199904)42:4<669::AID-ANR9>3.0.CO;2-V"},{"key":"key\n\t\t\t\t20170703123012_R15","doi-asserted-by":"crossref","unstructured":"Yudoh K, Matsuno H, Nakazawa F, Yonezawa T, Kimura T. Reduced expression on the regulatory CD4+ T cell subset is related to Th1\/Th2 balance and disease severity in rheumatoid arthritis. Arthritis Rheum2000;43:617\u201327.","DOI":"10.1002\/1529-0131(200003)43:3<617::AID-ANR19>3.0.CO;2-B"},{"key":"key\n\t\t\t\t20170703123012_R16","doi-asserted-by":"crossref","unstructured":"Rooney M, Condell D, Quinlan W et al. Analysis of the histologic variation of synovitis in rheumatoid arthritis. Arthritis Rheum1988;31:956\u201363.","DOI":"10.1002\/art.1780310803"},{"key":"key\n\t\t\t\t20170703123012_R17","doi-asserted-by":"crossref","unstructured":"Brouckaert P, Spriggs DR, Demtetri G, Kufe DW, Fiers W. Circulating interleukin 6 during a continuous infusion of tumor necrosis factor and interferon \u03b3. J Exp Med1989;169:2257\u201362.","DOI":"10.1084\/jem.169.6.2257"},{"key":"key\n\t\t\t\t20170703123012_R18","unstructured":"Proudman SM, Cleland LG, Mayrhofer G. Effects of tumor necrosis factor\u2010\u03b1, interleukin 1\u03b2, and activated peripheral blood mononuclear cells on the expression of adhesion molecules and recruitment of leukocytes in rheumatoid synovial xenografts in SCID mice. J Rheumatol1999;26:1877\u201389."},{"key":"key\n\t\t\t\t20170703123012_R19","unstructured":"Kavanaugh A, St Clair EW, McCune WJ, Braakman T, Lipsky P. Chimeric anti\u2010tumor necrosis factor\u2010alpha monoclonal antibody treatment of patients with rheumatoid arthritis receiving methotrexate therapy. J Rheumatol2000;27:841\u201350."},{"key":"key\n\t\t\t\t20170703123012_R20","unstructured":"Wendling D, Racadot E, Wijdenes J. Treatment of severe rheumatoid arthritis by anti\u2010interleukin 6 monoclonal antibody. J Rheumatol1993;20:259\u201362."},{"key":"key\n\t\t\t\t20170703123012_R21","doi-asserted-by":"crossref","unstructured":"Wahid S, Blades MC, DeLord D et al. Tumor necrosis factor\u2010alpha (TNF\u2010\u03b1) enhances lymphocyte migration into rheumatoid synovial tissue transplanted into severe combined immunodeficient (SCID) mice. Clin Exp Immunol2000;122:133\u201342.","DOI":"10.1046\/j.1365-2249.2000.01342.x"},{"key":"key\n\t\t\t\t20170703123012_R22","doi-asserted-by":"crossref","unstructured":"Husby G, Williams RC Jr. Synovial localization of tumor necrosis factor in patients with rheumatoid arthritis. J Autoimmun1988;31:363\u201371.","DOI":"10.1016\/0896-8411(88)90006-6"},{"key":"key\n\t\t\t\t20170703123012_R23","doi-asserted-by":"crossref","unstructured":"Neidel J, Schulze M, Lindschau J. Association between degree of bone erosion and synovial fluid levels of tumor necrosis factor a in the knee joints of patients with rheumatoid arthritis. Inflamm Res1995;44:217\u201321.","DOI":"10.1007\/BF01782262"},{"key":"key\n\t\t\t\t20170703123012_R24","doi-asserted-by":"crossref","unstructured":"Vassalli P. The pathophysiology of tumor necrosis factors. Annu Rev Immunol1992;10:411\u201352.","DOI":"10.1146\/annurev.iy.10.040192.002211"},{"key":"key\n\t\t\t\t20170703123012_R25","doi-asserted-by":"crossref","unstructured":"Kishimoto C. The biology of interleukin\u20106. Blood1989;74:1\u201310.","DOI":"10.1182\/blood.V74.1.1.1"},{"key":"key\n\t\t\t\t20170703123012_R26","doi-asserted-by":"crossref","unstructured":"Tamura T, Udagawa N, Takahashi N et al. Soluble interleukin\u20106 receptor triggers osteoclast formation by interleukin 6. Proc Natl Acad Sci USA1993;90:11924\u20138.","DOI":"10.1073\/pnas.90.24.11924"},{"key":"key\n\t\t\t\t20170703123012_R27","doi-asserted-by":"crossref","unstructured":"Houssiau FA, Devogelaer JP, van Damme J, de Deuxchaisnes CN, van Snick. Interleukin\u20106 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum1988;31:784\u20138.","DOI":"10.1002\/art.1780310614"},{"key":"key\n\t\t\t\t20170703123012_R28","doi-asserted-by":"crossref","unstructured":"Camussi G, Lupia E. The future role of anti\u2010tumor necrosis factor (TNF) products in the treatment of rheumatoid arthritis. Drugs1998;55:613\u201320.","DOI":"10.2165\/00003495-199855050-00001"},{"key":"key\n\t\t\t\t20170703123012_R29","doi-asserted-by":"crossref","unstructured":"van den Berg WB, van de Loo FA, Zwarts WA, Otterness IG. Effects of murine recombinant interleukin 1 on intact cartilage: a quantitative and autoradiographic study. Ann Rheum Dis1988;47:855\u201363.","DOI":"10.1136\/ard.47.10.855"},{"key":"key\n\t\t\t\t20170703123012_R30","unstructured":"van Lent PLEM, van De Loo FAJ, Holthuysen AEM, van den Bersselaar LAM, Vermeer H, van den Berg WB. Major role for interleukin 1 but not for tumour necrosis factor in early cartilage damage in immune complex arthritis in mice. J Rheumatol1995;22:2250\u20138."}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/41\/3\/329\/18095540\/410329.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T09:29:14Z","timestamp":1583314154000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-lookup\/doi\/10.1093\/rheumatology\/41.3.329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2002,3]]},"published-print":{"date-parts":[[2002,3]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/41.3.329","relation":{},"ISSN":["1462-0332","1462-0324"],"issn-type":[{"value":"1462-0332","type":"electronic"},{"value":"1462-0324","type":"print"}],"subject":[],"published":{"date-parts":[[2002,3]]}}}